Antibody Development & Production（抗體的開發和製造）
CSS
學會概要
Mix-and-match sessions from these additional co-located conferences at no additional cost:
- Recombinant Protein & Complex Biologic Development & Production
- Analytical Technologies for Biotherapeutic Development
- Biobetters & Biosimilars: Technologies & Development Strategies
Arrive early so you can attend the first half of the week, Feb. 27-28 for these conferences:
學會詳細介紹有助於各種規模的企業為開發或生產抗體、改善生產速度、品質和成本、以及在生物製程領域之技術面和科學面的新成果，是高水平的活動。能獲得只有在此學會才能聽到的個案研究，取得最新資料，藉由在策略性討論論壇與領導業界的研究人員、技術人員及企業主管交換意見，能找到業界面臨之最重要課題的解決辦法。
"IBC continues to put together a well organized series of conferences that cover the key topics and areas of interest across the biotech industry. They provide an excellent forum to bring together leading scientists and companies to exchange ideas and create networking contacts." - William D. Taylor, Director, Business Development, Pfenex
學會的優點
- 能針對促進製程技術創新、整合、最適化的許多新要因進行檢討
- 能學習利用高滴定率製程的綜合性方法
2012年的研習會介紹與下列主題有關的實績方法、個案研究及未發表的資料等
- 製程開發的新波－藉由技術創新、整合、最適化來改善生物製程
- 引進利用高滴定率製程之成本效率高的新方法
- 部分改善上游製程和下游製程的接點
- 抗體設計對開發和生產業務的影響
- 細胞株的選定、開發、設計手法之進化
- 克服開發高濃度製劑和傳遞時的課題
- 改善製程開發中的產品品質
- 特性描述和相似性的新方法與策略
- 藥物複合體的開發與生產
- 下一代的分子和新分子的開發與製造
在學會中能找到這些問題的解答。
Comparability Within A Single Product Differs from Biosimilarity Between Two Products
Anthony S. Lubiniecki, Sc.D.
Johnson & Johnson Pharmaceutical R&D, Inc.
Path to Approval for Antibody Drug Conjugates
Morris Rosenberg, D.Sc.
Seattle Genetics
Continuous Bioprocessing for Production of Biopharmaceuticals
Weichang Zhou, Ph.D.
Genzyme, a Sanofi Company
Application of Quality by Design Approach in Viral Clearance Studies: Be Prepared and Set a Realistic Expectation
Dayue Chen, Ph.D.
Eli Lilly and Company
Developing High Dose Monoclonal Antibody Formulations for SC Delivery
Steven J. Shire, Ph.D.
Genentech, Inc.
Special thanks to the Scientific Advisory Committee for their help in developing this program.
» View the list of committee members